Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-week versus 6-week doxycycline + streptomycin + hydroxychloroquine for brucellosis
IRCT20160523028008N4Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of doxycycline, streptomycin and hydroxychloroquine in brucellosis (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: response to treatment, recurrence and 1 more. Started Feb 2019; status: completed.
02
Drugs
doxycyclinestreptomycinhydroxychloroquine
03
Conditions
brucellosis
Beyond the preview
Go deeper on IRCT20160523028008N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160523028008N4.